Stryker Gestione
Gestione criteri di controllo 3/4
Stryker Il CEO è Kevin Lobo, nominato in Oct2012, e ha un mandato di 12.08 anni. la retribuzione annua totale è $ 20.77M, composta da 6.7% di stipendio e 93.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.026% delle azioni della società, per un valore di $ 38.76M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 6.2 anni e 6.5 anni.
Informazioni chiave
Kevin Lobo
Amministratore delegato
US$20.8m
Compenso totale
Percentuale dello stipendio del CEO | 6.7% |
Mandato del CEO | 12.1yrs |
Proprietà del CEO | 0.03% |
Durata media del management | 6.2yrs |
Durata media del Consiglio di amministrazione | 6.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?
Nov 21Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC
Oct 16We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Oct 10A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Sep 29Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Sep 18We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt
Sep 01Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't
Aug 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Aug 10Stryker: Wait For A Better Entry Point Post-Q2 Results
Aug 06Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?
Jul 11A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Jun 30Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80
Jun 19The Returns At Stryker (NYSE:SYK) Aren't Growing
Jun 16Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Jun 05Stryker: Margin Gains Should Drive Upside
May 31Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?
May 25Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings
May 14Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 02We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Apr 29Stryker: A Great Company At An Expensive Price
Apr 05Stryker's (NYSE:SYK) Dividend Will Be $0.80
Mar 26Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Mar 25Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns
Mar 14At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?
Feb 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Feb 10Stryker: A Dividend Growth Powerhouse I'd Like To Own
Feb 02Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly
Jan 24Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today
Jan 02Stryker: Mako Shoulder And Spine Launches Are On The Way
Dec 31Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 22Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 08Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital
Oct 19Stryker: Don't Buy This Dividend Champion (Yet)
Oct 13Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Oct 08Is Stryker (NYSE:SYK) A Risky Investment?
Sep 26Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$4b |
Jun 30 2024 | n/a | n/a | US$3b |
Mar 31 2024 | n/a | n/a | US$3b |
Dec 31 2023 | US$21m | US$1m | US$3b |
Sep 30 2023 | n/a | n/a | US$3b |
Jun 30 2023 | n/a | n/a | US$3b |
Mar 31 2023 | n/a | n/a | US$3b |
Dec 31 2022 | US$19m | US$1m | US$2b |
Sep 30 2022 | n/a | n/a | US$2b |
Jun 30 2022 | n/a | n/a | US$2b |
Mar 31 2022 | n/a | n/a | US$2b |
Dec 31 2021 | US$16m | US$1m | US$2b |
Sep 30 2021 | n/a | n/a | US$2b |
Jun 30 2021 | n/a | n/a | US$2b |
Mar 31 2021 | n/a | n/a | US$1b |
Dec 31 2020 | US$13m | US$1m | US$2b |
Sep 30 2020 | n/a | n/a | US$2b |
Jun 30 2020 | n/a | n/a | US$2b |
Mar 31 2020 | n/a | n/a | US$2b |
Dec 31 2019 | US$15m | US$1m | US$2b |
Sep 30 2019 | n/a | n/a | US$3b |
Jun 30 2019 | n/a | n/a | US$4b |
Mar 31 2019 | n/a | n/a | US$4b |
Dec 31 2018 | US$14m | US$1m | US$4b |
Sep 30 2018 | n/a | n/a | US$1b |
Jun 30 2018 | n/a | n/a | US$1b |
Mar 31 2018 | n/a | n/a | US$1b |
Dec 31 2017 | US$14m | US$1m | US$1b |
Compensazione vs Mercato: La retribuzione totale di Kevin ($USD 20.77M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 12.66M ).
Compensazione vs guadagni: La retribuzione di Kevin è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Kevin Lobo (59 yo)
12.1yrs
Mandato
US$20,767,847
Compensazione
Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Chairman | 12.1yrs | US$20.77m | 0.026% $ 38.8m | |
VP & CFO | 8.6yrs | US$6.84m | 0.0015% $ 2.3m | |
Group President of Global Quality & Operations | 6.6yrs | US$4.47m | 0.0024% $ 3.6m | |
Group President of MedSurg & Neurotechnology | 6.3yrs | US$6.49m | 0.015% $ 22.4m | |
Group President of Orthopaedics & Spine | 6.3yrs | US$6.49m | 0.014% $ 20.1m | |
VP & Chief Accounting Officer | 3.3yrs | Nessun dato | 0.00078% $ 1.1m | |
CTO and VP of Global R&D - Joint Replacement | no data | Nessun dato | Nessun dato | |
VP, Chief Information Officer & Chief Information Security Officer | 6.2yrs | Nessun dato | Nessun dato | |
Vice President of Finance & Investor Relations | 2.3yrs | Nessun dato | Nessun dato | |
VP & Chief Legal Officer | 5.6yrs | US$2.24m | 0.0024% $ 3.6m | |
VP & Chief Compliance Officer | no data | Nessun dato | Nessun dato | |
VP of Communications | 5.9yrs | Nessun dato | 0.0087% $ 12.7m |
6.2yrs
Durata media
57yo
Età media
Gestione esperta: Il team dirigenziale di SYK è esperto e expertise (durata media dell'incarico 6.2 anni).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
Chairman | 12.1yrs | US$20.77m | 0.026% $ 38.8m | |
Independent Director | 4.5yrs | US$319.25k | 0.00085% $ 1.2m | |
Director Emeritus | 6.5yrs | US$38.86k | Nessun dato | |
Chairman Emeritus | no data | US$286.99k | 5.26% $ 7.7b | |
Independent Director | 40.8yrs | US$319.25k | 4.77% $ 7.0b | |
Independent Director | 7.3yrs | US$334.25k | 0.0015% $ 2.2m | |
Independent Director | 13.8yrs | US$334.25k | 0.0039% $ 5.7m | |
Lead Independent Director | 6.5yrs | US$359.25k | 0.00022% $ 322.8k | |
Independent Director | 6.5yrs | US$319.25k | 0.0014% $ 2.0m | |
Independent Director | 3.9yrs | US$319.25k | 0.00067% $ 983.0k | |
Independent Director | 11yrs | US$339.25k | 0.0015% $ 2.1m | |
Independent Director | less than a year | Nessun dato | 0.000010% $ 14.7k |
6.5yrs
Durata media
59yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SYK sono considerati esperti (durata media dell'incarico 6.5 anni).